Evidence map›Paper›PMID 32802592›Full record

ArticleInnovations in clinical neuroscience2020

Scam Susceptibility in a Young, Schizoaffective Patient with Traumatic Brain Injury: A Case Report with a Review of Financial Exploitation Literature and Possible Therapeutic Interventions Gleaned from Traumatic Brain Injury Rehabilitation Research.

Paul C Mccormick, Jessica Simberlund

Open access · greenAbstract readCase Reports
In one paragraph

Article in Innovations in clinical neuroscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Paul C MccormickDrs. McCormick and Simberlund are with the Department of Psychiatry at Weill Cornell Medicine and the New York-Presbyterian Hospital in New York, New York.
Jessica SimberlundDrs. McCormick and Simberlund are with the Department of Psychiatry at Weill Cornell Medicine and the New York-Presbyterian Hospital in New York, New York.
NewYork–Presbyterian Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present here the case of a 27-year-old man with schizoaffective disorder for roughly eight years who, seven years prior to presentation at our institution, suffered a severe traumatic brain injury (TBI) in a car accident. His course since that time has been marked by paranoid and guilty delusions, Cotard delusion (CD), which is the belief he is dead or does not exist, and scam susceptibility leading to the loss of nearly $200,000. He was hospitalized at our institution after his uncle called emergency medical services, concerned about the patient's increasing disorganization and worsening delusions in the setting of medication nonadherence. In our inpatient unit, clozapine was titrated to its highest tolerable dose and, while reality testing appeared and his CD resolved, he remained acutely vulnerable to scams even while hospitalized. We review the existing literature on scam vulnerability, which heretofore has focused primarily on the elderly, and also TBI rehabilitation strategies in an attempt to better understand the underpinnings of this patient's scam susceptibility and to construct a multidisciplinary approach to lessening his susceptibility to financial exploitation in the future.

Indexed as

financial exploitationgullibilitymetacognitive strategy interventionscamsscam susceptibilitySchizoaffective disordertraumatic brain injurytraumatic brain injury rehabilitation

Identifiers

PMID32802592
PMCPMC7413337
OpenAlexW3081278692

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.